ArticleScientific reports2026
Soluble epoxide hydrolase inhibitory constituents from the Heartwood of Toxicodendron vernicifluum: isolation, kinetic characterization, molecular modeling, and quantitative analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anti-Inflammatory Activity of Monoterpene Phenol Dimers fromACS omega · 2026Article
- Identification of Anti-Viral Compounds fromJournal of microbiology and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Soluble epoxide hydrolase (sEH) is a pivotal therapeutic target for inflammation management, as it regulates the hydrolysis of anti-inflammatory epoxy fatty acids (EpFAs). In this study, we investigated the sEH inhibitory potential of Toxicodendron vernicifluum (Stokes) F.A. Barkley heartwood. Bioactivity-guided fractionation of the ethanol extract identified the ethyl acetate-soluble fraction as the most active fraction (~ 60% inhibition at 50 µg/mL). Subsequent purification yielded 11 polyphenols, all of which are known compounds previously reported from this species. While these are known phytochemicals, this study represents the first characterization of their inhibitory kinetics against sEH. Among the isolates, the aurone sulfuretin (7) and the flavonol fisetin (5) emerged as potent competitive inhibitors with IC50 values of 8.8 ± 0.3 µM and 9.6 ± 0.8 µM, respectively. Conversely, the chalcone butein (9) exhibited a distinct non-competitive mode of inhibition (IC50 = 21.4 ± 1.5 µM). Computational analyses, including molecular docking and 100 ns molecular dynamics (MD) simulations, elucidated the structural basis of these interactions. The simulations confirmed the stable engagement of sulfuretin within the catalytic pocket via hydrogen bonds with Asp335 and Tyr383, whereas docking studies indicated that butein occupies a peripheral allosteric site. These findings demonstrate that T. vernicifluum heartwood is a promising source of sEH inhibitors with dual mechanisms of action, highlighting its potential for development into anti-inflammatory therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.